Targeted_next-generation_sequencing_of_Felis_catus: N15_Control_Birman_Study_tNGS
The study consists of samples from 28 Birman pedigree cats (14 controls, 17 cases, including 8 cats with HCM, and 6 cats with RCM). Genomic DNA samples were subjected to targeted next-generation sequencing against a feline HCM gene panel, comprising 16 candidate genes linked to human cardiomyopathies (similar to Illumina TrueSight Cardio Panel). Sequencing was conducted at Edinburgh Genomics, employing SureSelect Target Enrichment technology on a MiSeq Illumina Platform.